Annual D&A
$1.75 M
-$137.00 K-7.25%
December 1, 2024
Summary
- As of March 12, 2025, CMPX annual depreciation & amortization is $1.75 million, with the most recent change of -$137.00 thousand (-7.25%) on December 1, 2024.
- During the last 3 years, CMPX annual D&A has risen by +$129.00 thousand (+7.94%).
- CMPX annual D&A is now -27.08% below its all-time high of $2.40 million, reached on December 1, 2020.
Performance
CMPX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$359.00 K
-$106.00 K-22.80%
December 1, 2024
Summary
- As of March 12, 2025, CMPX quarterly depreciation & amortization is $359.00 thousand, with the most recent change of -$106.00 thousand (-22.80%) on December 1, 2024.
- Over the past year, CMPX quarterly D&A has dropped by -$104.00 thousand (-22.46%).
- CMPX quarterly D&A is now -66.42% below its all-time high of $1.07 million, reached on December 1, 2020.
Performance
CMPX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.75 M
-$109.00 K-5.85%
December 1, 2024
Summary
- As of March 12, 2025, CMPX TTM depreciation & amortization is $1.75 million, with the most recent change of -$109.00 thousand (-5.85%) on December 1, 2024.
- Over the past year, CMPX TTM D&A has dropped by -$119.00 thousand (-6.36%).
- CMPX TTM D&A is now -27.08% below its all-time high of $2.40 million, reached on December 1, 2020.
Performance
CMPX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
CMPX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.3% | -22.5% | -6.4% |
| 3 y3 years | +7.9% | -22.5% | -6.4% |
| 5 y5 years | -17.3% | -22.5% | -6.4% |
CMPX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.9% | +7.9% | -27.9% | at low | -10.1% | +6.5% |
| 5 y | 5-year | -27.1% | +7.9% | -66.4% | at low | -27.1% | +278.6% |
| alltime | all time | -27.1% | +7.9% | -66.4% | at low | -27.1% | +278.6% |
Compass Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $1.75 M(-7.2%) | $359.00 K(-22.8%) | $1.75 M(-5.9%) |
| Sep 2024 | - | $465.00 K(-0.2%) | $1.86 M(-0.1%) |
| Jun 2024 | - | $466.00 K(+0.6%) | $1.86 M(-0.5%) |
| Mar 2024 | - | $463.00 K(-1.1%) | $1.87 M(-1.0%) |
| Dec 2023 | $1.89 M(-0.7%) | $468.00 K(+0.4%) | $1.89 M(-0.8%) |
| Sep 2023 | - | $466.00 K(-1.9%) | $1.91 M(-1.1%) |
| Jun 2023 | - | $475.00 K(-1.2%) | $1.93 M(-1.2%) |
| Mar 2023 | - | $481.00 K(-0.6%) | $1.95 M(+2.4%) |
| Dec 2022 | $1.90 M | $484.00 K(-0.6%) | $1.90 M(+4.8%) |
| Sep 2022 | - | $487.00 K(-2.2%) | $1.82 M(+4.7%) |
| Jun 2022 | - | $498.00 K(+14.5%) | $1.74 M(+5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $435.00 K(+9.8%) | $1.65 M(+1.4%) |
| Dec 2021 | $1.62 M(-32.4%) | - | - |
| Dec 2021 | - | $396.00 K(-2.5%) | $1.62 M(-29.3%) |
| Sep 2021 | - | $406.00 K(-0.7%) | $2.30 M(-1.2%) |
| Jun 2021 | - | $409.00 K(-1.0%) | $2.33 M(-1.2%) |
| Mar 2021 | - | $413.00 K(-61.4%) | $2.35 M(-2.1%) |
| Dec 2020 | $2.40 M(+13.4%) | $1.07 M(+145.7%) | $2.40 M(+80.1%) |
| Sep 2020 | - | $435.00 K(-0.5%) | $1.33 M(+48.3%) |
| Jun 2020 | - | $437.00 K(-5.6%) | $900.00 K(+94.4%) |
| Mar 2020 | - | $463.00 K | $463.00 K |
| Dec 2019 | $2.12 M(+10.4%) | - | - |
| Dec 2018 | $1.92 M | - | - |
FAQ
- What is Compass Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Compass Therapeutics?
- What is Compass Therapeutics annual D&A year-on-year change?
- What is Compass Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Compass Therapeutics?
- What is Compass Therapeutics quarterly D&A year-on-year change?
- What is Compass Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Compass Therapeutics?
- What is Compass Therapeutics TTM D&A year-on-year change?
What is Compass Therapeutics annual depreciation & amortization?
The current annual D&A of CMPX is $1.75 M
What is the all time high annual D&A for Compass Therapeutics?
Compass Therapeutics all-time high annual depreciation & amortization is $2.40 M
What is Compass Therapeutics annual D&A year-on-year change?
Over the past year, CMPX annual depreciation & amortization has changed by -$137.00 K (-7.25%)
What is Compass Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of CMPX is $359.00 K
What is the all time high quarterly D&A for Compass Therapeutics?
Compass Therapeutics all-time high quarterly depreciation & amortization is $1.07 M
What is Compass Therapeutics quarterly D&A year-on-year change?
Over the past year, CMPX quarterly depreciation & amortization has changed by -$104.00 K (-22.46%)
What is Compass Therapeutics TTM depreciation & amortization?
The current TTM D&A of CMPX is $1.75 M
What is the all time high TTM D&A for Compass Therapeutics?
Compass Therapeutics all-time high TTM depreciation & amortization is $2.40 M
What is Compass Therapeutics TTM D&A year-on-year change?
Over the past year, CMPX TTM depreciation & amortization has changed by -$119.00 K (-6.36%)